Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

[32] Therefore, chronic urticaria and/or angioedema are not considered indications for SIT ... demonstrated efficacy of six weekly injections of vaccine containing CpG conjugated to the major ...

Firstly, the patient would need to have an indication to receive the medicine ... with very little skin reactions at the injection site noted in patients who received the subcutaneous version, and ...

Bristol Myers (BMY) Squibb announced that the U.S. FDA granted approval for Opdivo Qvantig injection for subcutaneous use ... solid tumor Opdivo indications as monotherapy, monotherapy maintenance ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the ... across almost all of Opdivo's lengthy list of indications in nearly a dozen different types ...

Opdivo-Qvantig had a non-inferior objective response rate compared to intravenous formulation in patients with locally ...

that can be given by monthly subcutaneous injection in the EU. The green light means that anti-complement C5 antibody PiaSky (crovalimab) has now been cleared in the top four world pharma markets ...